AzTrials
AzTrials

Standard TrainingELSINCT02887339

Ethical, Legal, and Social Issues Substudy in Relation to the GTEx Project

A study testing Training Website in people with Standard Training and Online Training, run by Temple University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Ethical, Legal and Social Issues Substudy in relation to the Genotype Tissue Expression Project (GTEx) aims to describe tissue requesters' approach to discussions about donation to GTEx and to assess the determinants of families' and patients' willingness to donate to GTEx. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Standard Training, Online Training
What is being tested?
Training Website
Could I receive a placebo?
No, everyone receives an active treatment
How many people
512 participants
Where
1 siteUnited States
Study dates
Mar 2013to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Participants must either be a:
  • family decision maker approached to donate their loved one's tissues to the GTEx project or
  • a staff person at an OPO that approaches family decision makers for the GTEx project.

Who cannot join

  • 1. Persons who neither approached for GTEx or were approached are excluded from participation.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Virginia Commonwealth University

    Richmond, Virginia, 23219

Other trials in United States

About this study

Official title: Ethical, Legal, and Social Issues Substudy in Relation to the Genotype-Tissue Expression Project

The Ethical, Legal and Social Issues Substudy in relation to the Genotype Tissue Expression Project (GTEx) aims to describe tissue requesters' approach to discussions about donation to GTEx and to assess the determinants of families' and patients' willingness to donate to GTEx. It also explores ethical issues such as privacy, risks, and release of incidental findings and recommend best practices for conducting authorizations and training requesters.

Read the detailed description

The Genotype Tissue Expression Project (GTEx) is a partnership between multiple NIH agencies and funded by the Common Fund. Families who agreed to donation of organs and tissues for transplantation were asked to authorize the collection of additional tissues for GTEx by participating Organ Procurement Organizations (OPO). Donated tissues are placed in a National Cancer Institute biobank, and the donor's genome and medical record information analyzed and released to researchers through NIH's database of Genotypes and Phenotypes (dbGaP). The tissues and information will be kept in the biobank indefinitely and cell lines may be developed from the donated skin and blood.

An ethical, legal and social issues (ELSI) sub-study examines the issues surrounding risks to privacy and breach of confidentiality to family decision makers (FDM) as well as FDM perspectives on the return of findings to donor families. The ELSI sub-study assessed the authorization process and make suggestions for its improvement. Semi-structured interviews were completed with families who decided to donate to GTEx as well as those who refused to donate to the project. Tissue requesters (TR) who make the GTEx approaches for participating OPOs, were also asked to complete an online survey for each approach they completed for GTEx.

The study builds on this research team's extensive work in organ and tissue donation and the work currently being conducting during the ELSI pilot of the GTEx project. Specifically, the investigators propose to examine the impact of stress and complex information on donor families' decision-making to inform the consent process; understand how variations in requesters, consent approaches, and the characteristics of family decision makers affect understanding, recall of and willingness to donate tissues for research; consider the ethical and legal issues of the request and consent process; and, test a novel intervention designed to train tissue requesters to employ effective communication techniques when making requests for tissue. The overall goal is to develop a set of recommendations that will maximize the likelihood that family decision makers (FDM) make informed donation decisions under stressful circumstances. The specific aims of the ELSI GTEx study are:

This study will build on this research team's extensive work in organ and tissue donation and the work they are currently conducting during the ELSI pilot of the GTEx project. Specifically, the investigators propose to examine the impact of stress and complex information on the decision making of donor families to inform the consent process, understand how variations in requesters, consent approaches, and the characteristics of family decision makers affect understanding and recall of and willingness to donate tissues for research, consider the ethical and legal issues of the request and consent process, and test an intervention to train tissue requesters to employ effective communication techniques when making requests for tissue. The overall goal is to develop a set of recommendations that will maximize the likelihood that family decision makers (FDM) make informed donation decisions under stressful circumstances. The specific aims of the ELSI GTEx study are:

  1. Identify elements of nonverbal and relational communication impacting FDM knowledge, recall and GTEx decision making. Using the methods and procedures of the pilot study, the investigators will conduct an observational study of the GTEx request process to understand the communication-related variables impacting FDM knowledge, recall and decision making. In addition, a subsample of audiotapes will be obtained from tissue-only donors whose consent conversations are conducted by telephone and are audiotaped. This will provide information about the important nonverbal and relational elements of communication on the outcome variables. H1a. Sociodemographic characteristics of FDM will impact the major outcomes of interest to this study (recall, comprehension and consent). Specifically, FDM who have more education, are white, female and younger will be more likely to donate, have better recall and knowledge. H1b. Relational elements of communication, such as confirmational messages (e.g., messages that expressed validation or acceptance) or persuasive tactics such as credibility, altruism, or esteem, and engaging in a lengthier conversation will be associated with a greater likelihood to donate have better recall and knowledge. H1c. Tissue requesters' and FDMs' comfort speaking about GTEx, the proclivity of FDMs to ask question and engage more proactively in the conversation will be associated with a greater likelihood to donate have better recall and knowledge.
  2. Conduct a study, using a quasi-experimental design, to understand the impact of the stressful environment in which the requests occur. This study will assist the ELSI team to obtain an evidence base that will allow us to disentangle the effects of stress from the complexity of the information about the purpose of the donation and guide recommendations for a final consent process.
  3. Adapt and test a communication intervention targeting tissue requesters' (TR) use of effective, ethically acceptable techniques that maximize the likelihood of consent.

H3a. Post intervention, TRs will exhibit more relational communication with FDMs during requests. H3b. Post intervention, TRs will spend more time attending to the emotional needs of FDMs.

H3c. Post intervention, TRs will spend more time discussing information identified as important to informed decision making for tissue donation.

H3d. Post intervention, there will be overall higher consent rates for donation to the research.

Being tested
Training Website, Control
Keywords
Informed Consent, Research donation request, Effective Communication

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Training WebsiteOther

    Additional training website can be found at gtextraing.org

  • ControlOther

    Standard training given by OPOs and GTEx staff

Study groups in NCT02887339
Study groupRoleWhat they receive
Intervention GroupExperimentalTissue requesters from participating OPOs are randomly assigned to complete additional informed consent training through an interactive online training website.
Receives: Other: Training Website
Control GroupExperimentalThe control group of tissue requesters receive the standard training offered by their OPO and GTEx partners.
Receives: Other: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of family members who chose to donate to GTEx

    Number of family decision makers who choose to donate to GTEx

    Measured: Up to 8 months after donation request

Secondary outcomes (1)
  1. Knowledge and Comprehension of Elements of Consent

    Knowledge and comprehension were assessed by participant answers to questionnaire.

    Measured: Up to 8 months after donation request

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2016 (estimated)
  2. Study startMar 2013
  3. Primary completionAug 2016
  4. Study completionDec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
512 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02887339
Sponsor's protocol ID
10XS170
Acronym
ELSI
Status last verified
Mar 2021
First submitted
17 Dec 2015
Last updated
30 Mar 2021
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013 Jun;45(6):580-5. doi: 10.1038/ng.2653.

    PubMed 23715323

Questions about this trial

What is this clinical trial studying?

A study testing Training Website in people with Standard Training and Online Training, run by Temple University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of family members who chose to donate to GTEx (time frame: Up to 8 months after donation request). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02887339, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in